$AVNS
AVANOS MEDICAL, INC.

2023 Q2 Form 10-Q Financial Statement

#000160649823000041 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $169.4M $191.7M
YoY Change -16.55% -2.89%
Cost Of Revenue $71.60M $87.20M
YoY Change -18.73% -3.33%
Gross Profit $97.80M $104.5M
YoY Change -14.88% -2.52%
Gross Profit Margin 57.73% 54.51%
Selling, General & Admin $93.00M $92.70M
YoY Change 6.77% 2.89%
% of Gross Profit 95.09% 88.71%
Research & Development $6.800M $7.900M
YoY Change -15.0% 1.28%
% of Gross Profit 6.95% 7.56%
Depreciation & Amortization $4.500M $12.10M
YoY Change -61.21% 9.01%
% of Gross Profit 4.6% 11.58%
Operating Expenses $99.80M $100.6M
YoY Change 4.07% 2.76%
Operating Profit -$2.100M $2.600M
YoY Change -111.05% -71.74%
Interest Expense $3.500M $3.500M
YoY Change -240.0% 169.23%
% of Operating Profit 134.62%
Other Income/Expense, Net
YoY Change
Pretax Income -$5.100M -$400.0K
YoY Change -130.91% -105.06%
Income Tax -$800.0K $100.0K
% Of Pretax Income
Net Earnings -$68.10M -$500.0K
YoY Change -697.37% -108.62%
Net Earnings / Revenue -40.2% -0.26%
Basic Earnings Per Share -$1.46 -$0.01
Diluted Earnings Per Share -$1.46 -$0.01
COMMON SHARES
Basic Shares Outstanding 46.67M shares 46.60M shares
Diluted Shares Outstanding 46.80M shares 47.20M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.80M $95.70M
YoY Change -23.19% -8.25%
Cash & Equivalents $81.80M $95.70M
Short-Term Investments
Other Short-Term Assets $124.5M $15.40M
YoY Change 668.52% -1.91%
Inventory $148.3M $200.0M
Prepaid Expenses
Receivables $139.4M $131.0M
Other Receivables $12.90M $11.70M
Total Short-Term Assets $506.9M $453.8M
YoY Change 15.97% 3.32%
LONG-TERM ASSETS
Property, Plant & Equipment $122.6M $163.5M
YoY Change -38.14% -2.04%
Goodwill $762.6M $821.5M
YoY Change -0.54%
Intangibles $222.6M $244.7M
YoY Change -9.74%
Long-Term Investments
YoY Change
Other Assets $18.50M $18.60M
YoY Change -32.97% 16.98%
Total Long-Term Assets $1.160B $1.281B
YoY Change -11.85% -3.48%
TOTAL ASSETS
Total Short-Term Assets $506.9M $453.8M
Total Long-Term Assets $1.160B $1.281B
Total Assets $1.667B $1.735B
YoY Change -4.91% -1.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.40M $59.60M
YoY Change 1.87% -6.58%
Accrued Expenses $72.70M $80.60M
YoY Change -11.56% 8.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.200M $6.200M
YoY Change 31.91%
Total Short-Term Liabilities $160.5M $158.5M
YoY Change 6.22% 3.66%
LONG-TERM LIABILITIES
Long-Term Debt $203.3M $204.7M
YoY Change -18.45% -19.54%
Other Long-Term Liabilities $15.40M $15.50M
YoY Change -76.7% -44.64%
Total Long-Term Liabilities $15.40M $15.50M
YoY Change -95.12% -44.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $160.5M $158.5M
Total Long-Term Liabilities $15.40M $15.50M
Total Liabilities $431.9M $436.2M
YoY Change -13.83% -14.47%
SHAREHOLDERS EQUITY
Retained Earnings -$321.7M -$253.6M
YoY Change -16.72%
Common Stock $500.0K $500.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.235B $1.299B
YoY Change
Total Liabilities & Shareholders Equity $1.667B $1.735B
YoY Change -4.91% -1.79%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$68.10M -$500.0K
YoY Change -697.37% -108.62%
Depreciation, Depletion And Amortization $4.500M $12.10M
YoY Change -61.21% 9.01%
Cash From Operating Activities -$2.600M -$6.800M
YoY Change -109.63% -477.78%
INVESTING ACTIVITIES
Capital Expenditures $4.000M $4.000M
YoY Change -197.56% -180.0%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$2.500M $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.500M -$4.000M
YoY Change 58.54% -96.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.100M -$22.10M
YoY Change -75.74% -120.91%
NET CHANGE
Cash From Operating Activities -2.600M -$6.800M
Cash From Investing Activities -6.500M -$4.000M
Cash From Financing Activities -4.100M -$22.10M
Net Change In Cash -13.20M -$32.00M
YoY Change -320.0% 125.35%
FREE CASH FLOW
Cash From Operating Activities -$2.600M -$6.800M
Capital Expenditures $4.000M $4.000M
Free Cash Flow -$6.600M -$10.80M
YoY Change -121.22% -258.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001606498
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36440
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
AVANOS MEDICAL, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4987888
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5405 Windward Parkway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100 South
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Alpharetta,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30004
CY2023Q1 dei City Area Code
CityAreaCode
(844)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
428-2667
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock - $0.01 Par Value
CY2023Q1 dei Trading Symbol
TradingSymbol
AVNS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 us-gaap Interest Expense
InterestExpense
1300000 usd
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46666812 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
191700000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197400000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87200000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90800000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
104500000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
106600000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7900000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7800000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
92700000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
90100000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1300000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-100000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2600000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8600000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
500000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
3500000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-400000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7300000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1900000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-500000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5400000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-500000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5400000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4500000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4500000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1700000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4000000.0 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7100000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95700000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127700000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
142700000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
167900000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
200000000.0 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
190300000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15400000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13900000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
453800000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
499800000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
163500000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
163900000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28300000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30600000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
821500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
819400000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
244700000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
251000000.0 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4500000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4600000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18600000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17600000 usd
CY2023Q1 us-gaap Assets
Assets
1734900000 usd
CY2022Q4 us-gaap Assets
Assets
1786900000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6200000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6200000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12100000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12800000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
59600000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
67900000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
80600000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
98900000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
158500000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
185800000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
204700000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
226300000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32400000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34700000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
25100000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
25400000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15500000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23500000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
436200000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
495700000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Depreciation
Depreciation
5800000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
5400000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46660199 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46528907 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
500000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
500000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1651000000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1646400000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253600000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253100000 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
67900000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
66800000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31300000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35800000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1298700000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1291200000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1734900000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1786900000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1298700000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1262800000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-500000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5400000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12100000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11100000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4000000.0 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3800000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26200000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15700000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8600000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3900000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1500000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-100000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-7900000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
30200000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-27500000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-28800000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-3100000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-400000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6800000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1800000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4000000.0 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5000000.0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
116700000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4000000.0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121700000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
125000000.0 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1600000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
20000000.0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000.0 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000.0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1100000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19400000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
600000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
600000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
700000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22100000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105700000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
900000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32000000.0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14200000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127700000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118500000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95700000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104300000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of any change could be material to our financial statements. Changes in these estimates are recorded when known.</span></div>
CY2023Q1 avns Restructuring Plan Term
RestructuringPlanTerm
P3Y
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6300000 usd
CY2023Q1 avns Business Combination Income Tax Adjustment Decrease In Indemnification Liability
BusinessCombinationIncomeTaxAdjustmentDecreaseInIndemnificationLiability
100000 usd
CY2023Q1 avns Business Combination Income Tax Adjustment Decrease In Deferred Tax Liability
BusinessCombinationIncomeTaxAdjustmentDecreaseInDeferredTaxLiability
400000 usd
CY2023Q1 avns Business Combination Income Tax Adjustment Decrease In Accounts Receivables
BusinessCombinationIncomeTaxAdjustmentDecreaseInAccountsReceivables
2100000 usd
CY2023Q1 avns Business Combination Income Tax Adjustment Decrease In Goodwill
BusinessCombinationIncomeTaxAdjustmentDecreaseInGoodwill
1800000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
137400000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
162100000 usd
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
11700000 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
12200000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
142700000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
167900000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
300000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
57000000.0 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
53600000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
31200000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
31200000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
103400000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
97700000 usd
CY2023Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
8400000 usd
CY2022Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
7800000 usd
CY2023Q1 us-gaap Inventory Gross
InventoryGross
200000000.0 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
190300000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
2000000 usd
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
4400000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
325400000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
318900000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
161900000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
155000000.0 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
163500000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
163900000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
819400000 usd
CY2023Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1800000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-300000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
821500000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
558900000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
314200000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
244700000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
558900000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
307900000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
251000000.0 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5700000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
19000000.0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
25300000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24700000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24300000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24100000 usd
CY2023Q1 avns Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
127300000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
244700000 usd
CY2023Q1 avns Accrued Rebates And Customer Incentives
AccruedRebatesAndCustomerIncentives
18800000 usd
CY2022Q4 avns Accrued Rebates And Customer Incentives
AccruedRebatesAndCustomerIncentives
26900000 usd
CY2023Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
21800000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
34600000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
20800000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
21200000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19200000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16200000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
80600000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
98900000 usd
CY2023Q1 avns Accrued Compensation Benefits
AccruedCompensationBenefits
5400000 usd
CY2022Q4 avns Accrued Compensation Benefits
AccruedCompensationBenefits
4800000 usd
CY2023Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
10100000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
18700000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15500000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23500000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5400000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
211800000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
233400000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
900000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
900000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6200000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6200000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
204700000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
226300000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6200000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4700000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7000000.0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9400000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
10200000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
180500000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
211800000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4500000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4500000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4500000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1700000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46600000 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4000000.0 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3800000 usd
CY2021Q3 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
22200000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-500000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47400000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
600000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47200000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47800000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000 shares
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
191700000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197400000 usd
CY2023Q1 avns Accrued Rebates
AccruedRebates
9600000 usd
CY2022Q4 avns Accrued Rebates
AccruedRebates
14500000 usd
CY2023Q1 avns Accrued Incentives
AccruedIncentives
9200000 usd
CY2022Q4 avns Accrued Incentives
AccruedIncentives
12400000 usd
CY2023Q1 avns Accrued Rebates And Incentives
AccruedRebatesAndIncentives
18800000 usd
CY2022Q4 avns Accrued Rebates And Incentives
AccruedRebatesAndIncentives
26900000 usd
CY2023Q1 avns Accrued Sales Returns
AccruedSalesReturns
100000 usd
CY2022Q4 avns Accrued Sales Returns
AccruedSalesReturns
100000 usd
CY2023Q1 avns Liabilities For Estimated Rebates And Incentives Net
LiabilitiesForEstimatedRebatesAndIncentivesNet
18900000 usd
CY2022Q4 avns Liabilities For Estimated Rebates And Incentives Net
LiabilitiesForEstimatedRebatesAndIncentivesNet
27000000.0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001606498-23-000041-index-headers.html Edgar Link pending
0001606498-23-000041-index.html Edgar Link pending
0001606498-23-000041.txt Edgar Link pending
0001606498-23-000041-xbrl.zip Edgar Link pending
avns-20230331.htm Edgar Link pending
avns-20230331.xsd Edgar Link pending
avns-20230331_g1.jpg Edgar Link pending
avns-20230331_cal.xml Edgar Link unprocessable
avns-20230331_def.xml Edgar Link unprocessable
avns-20230331_lab.xml Edgar Link unprocessable
avns-20230331_pre.xml Edgar Link unprocessable
avns-20230331_htm.xml Edgar Link completed
avns1q2023form10qex1022.htm Edgar Link pending
avns1q2023form10qex1023.htm Edgar Link pending
avns1q2023form10qex31a.htm Edgar Link pending
avns1q2023form10qex31b.htm Edgar Link pending
avns1q2023form10qex32a.htm Edgar Link pending
avns1q2023form10qex32b.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending